RNA, U6 small nuclear 353, pseudogene (RNU6-353P)

RNU6-353P (RNA, U6 small nuclear 353, pseudogene) is a **pseudogene** corresponding to a U6 small nuclear RNA (snRNA) gene variant. U6 snRNA is a fundamental non-coding RNA component of the spliceosome, an RNA-protein complex responsible for catalyzing the removal of introns from pre-mRNA in eukaryotic cells, which is essential for correct gene expression[5][3]. However, **RNU6-353P itself does not produce a functional RNA or protein product**; as a pseudogene, it is a non-functional genomic remnant resulting from duplication or retrotransposition events and thus does not play an active role in spliceosomal RNA biology[1][4]. There is no evidence that RNU6-353P serves as a therapeutic target, biomarker, or interacts with drugs, nor is there information on its role in human disease. The entry is potentially misleading as a molecular target because **pseudogenes are typically considered non-functional genetic elements** that do not encode active proteins or functional RNAs[1][4][5]. The canonical U6 snRNA (not the pseudogene) is highly conserved and biologically essential, but the pseudogene variant (like RNU6-353P) is **not** considered a direct therapeutic target or functionally relevant in molecular medicine[1][5][4]. Notes on target status and correctness: - This entry refers to a **pseudogene**, not an active or functional target. - It is **not** a receptor, enzyme, transporter, or classical therapeutic target molecule. - There are no reports of clinical or pharmacological relevance for RNU6-353P itself.

Other names

RNU6-353P